JF
ARCT icon

Jump Financial’s Arcturus Therapeutics ARCT Stock Holding History

Jump Financial’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$929K Buy
138,209
+69,916
+102% +$551K 0.01% 1225
2026
Q1 		$527K Buy
+68,293
New +$498K 0.01% 1212
2025
Q1 		– Sell
-58,308
Closed -$989K – 1576
2024
Q4 		$989K Sell
58,308
-2,458
-4% -$46.3K 0.02% 757
2024
Q3 		$1.41M Buy
60,766
+44,918
+283% +$961K 0.03% 651
2024
Q2 		$386K Buy
+15,848
New +$481K 0.01% 1252
2023
Q3 		– Sell
-7,992
Closed -$229K – 1826
2023
Q2 		$229K Sell
7,992
-33,749
-81% -$919K 0.01% 1456
2023
Q1 		$1M Buy
41,741
+21,263
+104% +$381K 0.04% 597
2022
Q4 		$347K Buy
+20,478
New +$357K 0.02% 955
2022
Q3 		– Sell
-24,954
Closed -$393K – 1560
2022
Q2 		$393K Buy
+24,954
New +$490K 0.02% 949
2022
Q1 		– Sell
-30,443
Closed -$1.13M – 1528
2021
Q4 		$1.13M Buy
+30,443
New +$1.24M 0.07% 355
2021
Q2 		– Sell
-35,400
Closed -$1.46M – 1069
2021
Q1 		$1.46M Buy
+35,400
New +$2.11M 0.14% 166

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jump Financial's ARCT Position: Q2 2026 in Review

Jump Financial increased its Arcturus Therapeutics (ARCT) stake by 102% in Q2 2026, buying an estimated $551K and bringing the position to 138,209 shares worth $929K. The position accounts for 0.01% of the portfolio, ranked #1225.

Jump Financial first reported a position in ARCT in Q1 2021 and has held it in 11 quarters since. The position peaked at $1.46M in Q1 2021. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Jump Financial held 138,209 shares of Arcturus Therapeutics worth $929K as of Q2 2026.
  • Jump Financial bought 69,916 Arcturus Therapeutics shares in Q2 2026, an estimated $551K.
  • Arcturus Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1225 holding.
  • Jump Financial first reported a position in Arcturus Therapeutics in Q1 2021 and has held it in 11 quarters since.
  • Jump Financial's Arcturus Therapeutics position peaked at $1.46M in Q1 2021.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.